Could psychedelics be fine-tuned to relieve anxiety but skip the ‘trip’?

Cory A. Knox and Alex C. Kwan ()

Nature, 2025, vol. 639, issue 8053, 45-46

Abstract: Interest in psychedelic substances as medicines is rising. Identifying the neural circuits that mediate the benefits of psychedelics could pave the way for long-lasting anxiety treatments without the short-term sensory disturbances.

Keywords: Psychiatric disorders; Neuroscience; Brain (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-025-00454-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:639:y:2025:i:8053:d:10.1038_d41586-025-00454-z

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-025-00454-z

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().